PROPENSITY SCORE MATCHED OUTCOMES OF HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS WITH PULMONARY HYPERTENSION

被引:0
|
作者
Patel, Krunalkumar [1 ]
Patel, Kirtenkumar [1 ]
Khan, Muhammad Zubair [1 ]
Patel, Harsh [1 ]
Patel, Amitkumar [1 ]
Thakkar, Samarthkumar [1 ]
Adalja, Devina [1 ]
Patel, Umang [1 ]
Figueredo, Vincent [1 ]
机构
[1] St Mary Hosp, Langhorne, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:800 / 800
页数:1
相关论文
共 50 条
  • [41] Tofogliflozin Improves Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction Mice
    Joki, Yusuke
    Konishi, Hakuoh
    Takasu, Kiyoshi
    Minamino, Tohru
    CIRCULATION, 2020, 142
  • [42] Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
    Dachs, Theresa-Marie
    Duca, Franz
    Rettl, Rene
    Binder-Rodriguez, Christina
    Dalos, Daniel
    Ligios, Luciana Camuz
    Kammerlander, Andreas
    Grunig, Ekkehard
    Pretsch, Ingrid
    Steringer-Mascherbauer, Regina
    Ablasser, Klemens
    Wargenau, Manfred
    Mascherbauer, Julia
    Lang, Irene M.
    Hengstenberg, Christian
    Badr-Eslam, Roza
    Kastner, Johannes
    Bonderman, Diana
    EUROPEAN HEART JOURNAL, 2022, 43 (36) : 3402 - 3413
  • [43] Impact of the New Definition of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
    Sera, Fusako
    Ohtani, Tomohito
    Nakamoto, Kei
    Hikoso, Shungo
    Nakatani, Daisaku
    Tamaki, Shunsuke
    Yano, Masamichi
    Hayashi, Takaharu
    Nakagawa, Akito
    Nakagawa, Yusuke
    Yasumura, Yoshio
    Yamada, Takahisa
    Yamauchi-Takihara, Keiko
    Sakata, Yasushi
    CIRCULATION, 2020, 142
  • [44] Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction
    Agarwal, Richa
    Shah, Sanjiv J.
    Foreman, Aimee J.
    Glassner, Cherylanne
    Bartolome, Sonja D.
    Safdar, Zeenat
    Coslet, Sandra L.
    Anderson, Allen S.
    Gomberg-Maitland, Mardi
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (05): : 467 - 477
  • [45] Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
    Ovchinnikov, Artem
    Potekhina, Alexandra
    Belyavskiy, Evgeny
    Ageev, Fail
    PHARMACEUTICALS, 2022, 15 (08)
  • [46] Pulmonary arterial hypertension and heart failure with preserved ejection fraction: are they so discordant?
    Ruocco, Gaetano
    Gavazzi, Antonello
    Gonnelli, Stefano
    Palazzuoli, Alberto
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (03) : 534 - 545
  • [47] Pathobiological characterization of pulmonary hypertension associated with heart failure with preserved ejection fraction
    Zimmermann, L.
    Mueller, R.
    Gnatzy-Feik, L.
    Berghausen, E.
    Zierden, M.
    Vantler, M.
    Baldus, S.
    Rosenkranz, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [48] Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction
    Fares, Wassim H.
    Kaminski, Naftali
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 56 (04) : 421 - 422
  • [49] Metabolic Syndrome Exacerbates Pulmonary Hypertension In Heart Failure With Preserved Ejection Fraction
    Potus, F.
    Ranchoux, B.
    Tremblay, E.
    Provencher, S.
    Bonnet, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [50] Out-of-Proportion Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction
    Adir, Yochai
    Humbert, Marc
    Sitbon, Olivier
    Wolf, Rafael
    Lador, Frederic
    Jais, Xavier
    Simonneau, Gerald
    Amir, Offer
    RESPIRATION, 2013, 85 (06) : 471 - 477